Dados a serem apresentados na Conferência Virtual ISIRV-WHO 2021 WALTHAM, Mass., Oct. 19, 2021 (GLOBE NEWSWIRE) — A Adagio Therapeutics, Inc., (Nasdaq: ADGI) uma empresa biofarmacêutica de estágio clínico focada na descoberta, desenvolvimento e comercialização de soluções com base em anticorpos para doenças infecciosas com potencial pandêmico, divulgou hoje novos dados in vitro demonstrando a […]
Day: October 20, 2021
Adagio Therapeutics annonce de nouvelles données in vitro mettant en évidence une activité neutralisante large et puissante de l’ADG20 contre tous les variants connus du SARS-CoV-2
Les données seront présentées lors de la conférence virtuelle ISIRV-OMS 2021 WALTHAM, Massachusetts, 19 oct. 2021 (GLOBE NEWSWIRE) — Adagio Therapeutics, Inc. (Nasdaq : ADGI), une société biopharmaceutique au stade clinique axée sur la découverte, le développement et la commercialisation de solutions à base d’anticorps pour les maladies infectieuses à potentiel pandémique, a annoncé aujourd’hui de […]
Bill & Melinda Gates Foundation Commits up to $120 Million to Accelerate Access to COVID-19 Drug for Lower-Income Countries, Calls on Other Donors to Mobilize Resources
Financial commitment aims to secure dedicated, low-cost supply of molnupiravir, if the drug is authorized by regulators; builds on long-term efforts to increase access to tests, treatments, vaccines SEATTLE, Oct. 20, 2021 /PRNewswire/ — The Bill & Melinda Gates Foundation announced today a commitment of up to $120 million to accelerate access to the investigational antiviral […]